Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | See Remarks | September 30, 2024 | October 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date September 30, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 695,654 |
Reported balance
After 2024-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-09-30 · Sale · Disposed 19,782 · Balance 695,654 F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2: This sale price represents the weighted average sale price of the shares sold ranging from $1.71 to $1.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3: Includes 3,176 shares purchased on September 3, 2024 under the Company's 2010 Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2: This sale price represents the weighted average sale price of the shares sold ranging from $1.71 to $1.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: Includes 3,176 shares purchased on September 3, 2024 under the Company's 2010 Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2024 Filed Oct 2, 2024 20:13 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 19,782 | $1.72 | $34,064.60 |
DisclosureSEC source: 0001299130-24-000177 · wk-form4_1727900024.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 695,654 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.71 to $1.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 3,176 shares purchased on September 3, 2024 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:22 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 5,275 | $4.87 | $25,694.53 |
DisclosureSEC source: 0001299130-24-000070 · wk-form4_1709763753.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 712,260 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $4.72 to $5.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 2,085 shares purchased on March 1, 2024 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:36 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 432,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-24-000042 · wk-form4_1708983355.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 715,450 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2025, 2026, 2027, and 2028, provided that the Reporting Person continues to serve through each applicable vesting date. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 23:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 831 | $5.26 | $4,371.89 |
DisclosureSEC source: 0001299130-24-000025 · wk-form4_1708557415.xml · nonDerivative · entry 2 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,758 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $5.09 to $5.76 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 23:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 22,496 | $5.96 | $134,031.17 |
DisclosureSEC source: 0001299130-24-000025 · wk-form4_1708557415.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,589 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $5.69 to $6.65 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 22:47 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 19,257 | $8.44 | $162,471.31 |
DisclosureSEC source: 0001299130-23-000117 · wf-form4_169602763681560.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,085 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $8.39 to $8.51 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 1,837 shares purchased on September 1, 2023 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:46 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 5,045 | $9.49 | $47,892.19 |
DisclosureSEC source: 0001299130-23-000038 · certent-form4.xml · nonDerivative · entry 2 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,505 F3 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $9.24 to $9.71 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:46 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 164,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-23-000038 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,550 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date. F2 · balance_after: Includes 1,769 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 12:39 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 907 | $10.27 | $9,315.80 |
DisclosureSEC source: 0001299130-23-000026 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,581 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $9.80 to $10.82 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 12:22 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 12,968 | $5.61 | $72,802.35 |
DisclosureSEC source: 0001299130-22-000114 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,488 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $5.41 to $5.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 1,490 shares purchased on September 1, 2021, March 1, 2022 and September 1, 2022 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 00:27 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 239,000 | $0.00 Strike: $11.70 | $0.00 |
DisclosureSEC source: 0001299130-22-000039 · certent-form4.xml · derivative · entry 2 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,000 Underlying: Common Stock · 239,000 shares Expires 2032-03-02 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 00:27 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-22-000039 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,966 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:47 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 1,062 | $11.06 | $11,745.72 |
DisclosureSEC source: 0001299130-22-000026 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,966 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $11.060 to $11.065 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 21:31 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 20,272 | $25.75 | $522,004.00 |
DisclosureSEC source: 0001299130-21-000210 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,028 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $25.61 to $25.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:40 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 12,600 | $0.00 Strike: $46.37 | $0.00 |
DisclosureSEC source: 0001299130-21-000064 · certent-form4.xml · derivative · entry 2 Kim Susan G. · CIK 0001825421 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,600 Underlying: Common Stock · 12,600 shares Expires 2031-02-16 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:40 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-21-000064 · certent-form4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,300 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 16 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:14 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001209191-20-052446 · doc4.xml · derivative · entry 2 Kim Susan G. · CIK 0001825421 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2030-09-28 F2 · derivative.exercise_date: 1/4 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next three years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:14 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052446 · doc4.xml · nonDerivative · entry 1 Kim Susan G. · CIK 0001825421 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on September 28 of each of 2021, 2022, 2023, and 2024, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.